10x Genomics, Inc. (TXG) Financials

TXG Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.0 billion 201.4 million
Dec. 31, 2025 1.0 billion 245.0 million
Sept. 30, 2025 1.0 billion 242.2 million
June 30, 2025 980.0 million 206.7 million

TXG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 24.5 million 22.6 million
Dec. 31, 2025 39.0 million 25.2 million
Sept. 30, 2025 42.5 million 25.3 million
June 30, 2025 16.1 million 27.6 million

TXG Net Income

No data available :(

TXG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 539.8 million 70.1 million 81.4 million
Dec. 31, 2025 523.4 million 73.4 million 73.4 million
Sept. 30, 2025 482.1 million 76.4 million 76.4 million
June 30, 2025 447.3 million - 86.7 million

TXG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 128.3 million
Dec. 31, 2025 127.1 million
Sept. 30, 2025 125.5 million
June 30, 2025 124.5 million

TXG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.6 million 56.8 million 66.4 million -
Dec. 31, 2025 1.8 million 56.0 million 76.6 million -
Sept. 30, 2025 687000 57.2 million 75.4 million -
June 30, 2025 1.6 million 61.2 million 74.4 million -

TXG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 150.8 million 44.7 million
Dec. 31, 2025 166.0 million 53.0 million
Sept. 30, 2025 149.0 million 48.7 million
June 30, 2025 172.9 million 47.8 million

TXG Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TXG

Price: $31.04

52 week price:
8.95
33.50

Earnings Per Share: -0.17 USD

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Country: United States

Volume: 10738

Market Capitalization: 4.0 billion

Links: